CIENCIASMEDICASNEWS: Colchicine and aspirin in community patients with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial - The Lancet Respiratory Medicine

sábado, 15 de octubre de 2022

Colchicine and aspirin in community patients with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial - The Lancet Respiratory Medicine

Colchicine and aspirin in community patients with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial - The Lancet Respiratory Medicine

No hay comentarios:

Publicar un comentario

Suscribirse a: Enviar comentarios (Atom)